Cargando…

Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

Detalles Bibliográficos
Autores principales:	Ahmadi, Seyed Esmaeil, Rahimi, Samira, Zarandi, Bahman, Chegeni, Rouzbeh, Safa, Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414674/ https://www.ncbi.nlm.nih.gov/pubmed/34474678 http://dx.doi.org/10.1186/s13045-021-01152-9

Ejemplares similares

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
por: Ahmadi, Seyed Esmaeil, et al.
Publicado: (2021)

Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment
por: Valikhani, Mohsen, et al.
Publicado: (2021)

Correction: Wnt signaling promotes oncogenic transformation by inhibiting c-Myc–induced apoptosis
por: You, Zongbing, et al.
Publicado: (2021)

Author Correction: TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells
por: Whillock, Amy L., et al.
Publicado: (2019)

Author Correction: Multipurpose silicon photonics signal processor core
por: Pérez, Daniel, et al.
Publicado: (2017)

Multiwireand multipurpose
Publicado: (1972)

A straightforward microfluidic-based approach toward optimizing transduction efficiency of HIV-1-derived lentiviral vectors in BCP-ALL cells
por: Ahmadi, Seyed Esmaeil, et al.
Publicado: (2023)

Bamboo: the multipurpose plant
por: Akinlabi, Esther Titilayo, et al.
Publicado: (2017)

Oncogenic MYC amplifies mitotic perturbations
por: Littler, Samantha, et al.
Publicado: (2019)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

Correction: Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response
Publicado: (2020)

Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
por: Kraehn, G M, et al.
Publicado: (2001)

The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunocytochemistry.
por: Jack, A. S., et al.
Publicado: (1986)

Coamplification of the L‐myc and N‐myc Oncogenes in a Neuroblastoma Cell Line
por: Jinbo, Takeshi, et al.
Publicado: (1989)

The omnitron: a multipurpose accelerator
por: Lawrence Berkeley Nat. Laboratory. Berkeley
Publicado: (1966)

Resist nanokirigami for multipurpose patterning
por: Liu, Qing, et al.
Publicado: (2021)

Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012)

Myc, Oncogenic Protein Translation, and the Role of Polyamines
por: Flynn, Andrea T., et al.
Publicado: (2018)

High Intrinsic Oncogenic Potential in the Myc-Box-Deficient Hydra Myc3 Protein
por: Lechable, Marion, et al.
Publicado: (2023)

Pooled Prevalence Estimate of Ocular Manifestations in COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Soltani, Saber, et al.
Publicado: (2022)

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
por: Chen, Bing-Jia, et al.
Publicado: (2014)

Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers
por: Vízkeleti, Laura, et al.
Publicado: (2023)

Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
por: Gialeli, Chrysostomi, et al.
Publicado: (2023)

Detection of the c-myc oncogene product in testicular cancer.
por: Sikora, K., et al.
Publicado: (1985)

Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
por: Barna, Maria, et al.
Publicado: (2008)

Targeting oncogenic Myc as a strategy for cancer treatment
por: Chen, Hui, et al.
Publicado: (2018)

AMPLIFIED ALLELE OF THE HUMAN N‐myc ONCOGENE IN NEUROBLASTOMAS
por: Yamada, Masao, et al.
Publicado: (1988)

MYC Oncogene Contributions to Release of Cell Cycle Brakes
por: García-Gutiérrez, Lucía, et al.
Publicado: (2019)

Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene
por: Demma, Mark J., et al.
Publicado: (2019)

Correction: Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
por: Aird, Fraser, et al.
Publicado: (2018)

Multipurpose HiRadMat Experiment
por: Ordan, Julien Marius, et al.
Publicado: (2018)

Micromegas, a multipurpose gaseous detector
por: Charpak, Georges, et al.
Publicado: (2002)

A CMS Multipurpose Maintenance Platform
por: Barone, M, et al.
Publicado: (2007)

Multipurpose cell-based fascin bioassay
Publicado: (2013)

A Multipurpose CMOS Platform for Nanosensing
por: Bonanno, Alberto, et al.
Publicado: (2016)

A COVID-19 Multipurpose Platform
por: Petrellis, Nikos
Publicado: (2020)

Formation Mechanism of Multipurpose Silica Nanocapsules
por: Graham, Michael, et al.
Publicado: (2021)

A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B and T cell malignancies
por: Ortega, Manoela, et al.
Publicado: (2014)

MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination
por: Wu, Xiaofang, et al.
Publicado: (2021)

Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer
por: Zhang, Lingyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lvarq648ev0pock80tngs3nl89